Cite
HARVARD Citation
Porth, I. et al. (2023). Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. European journal of cancer. pp. 119-130. [Online].